2013
DOI: 10.1186/1471-2369-14-187
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan

Abstract: BackgroundHepatitis C virus (HCV) infection and chronic kidney disease (CKD) have high prevalences in Taiwan and worldwide, but the role of HCV infection in causing CKD remains uncertain. This cohort study aimed to explore this association.MethodsThis nationwide cohort study examined the association of HCV with CKD by analysis of sampled claims data from Taiwan National Health Insurance Research Database from 1998 to 2004. ICD-9 diagnosis codes were used to identify diseases. We extracted data of 3182 subjects… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
44
1

Year Published

2015
2015
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 37 publications
(45 citation statements)
references
References 45 publications
(115 reference statements)
0
44
1
Order By: Relevance
“…As an example, data on HCV RNA, the socioeconomic status, compliance with medical visits over follow-up, and substance abuse which are important potential confounders were incomplete. The link between HCV and CKD persisted (aHR 1.75; 95 % CI 1.25; 2.43, P = 0.0009) in a novel survey from Taiwan, where HCVinfected subjects with conventional risk factors for CKD (diabetes, hypertension, coronary artery disease, hyperlipidemia, and cirrhosis) were excluded [16]. Finally, our subgroup analysis with meta-regression was not able to capture all the sources of heterogeneity we have observed.…”
Section: Discussioncontrasting
confidence: 53%
See 1 more Smart Citation
“…As an example, data on HCV RNA, the socioeconomic status, compliance with medical visits over follow-up, and substance abuse which are important potential confounders were incomplete. The link between HCV and CKD persisted (aHR 1.75; 95 % CI 1.25; 2.43, P = 0.0009) in a novel survey from Taiwan, where HCVinfected subjects with conventional risk factors for CKD (diabetes, hypertension, coronary artery disease, hyperlipidemia, and cirrhosis) were excluded [16]. Finally, our subgroup analysis with meta-regression was not able to capture all the sources of heterogeneity we have observed.…”
Section: Discussioncontrasting
confidence: 53%
“…We retrieved 25 studies that met our inclusion criteria, of which two [16,17] reported outcomes from the same cohort and were excluded; a total of 23 studies were retrieved. The studies were published in 17 various articles [18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34] and carried out in 4 countries ( Fig.…”
Section: Literature Reviewmentioning
confidence: 99%
“…These associations were present in HCV‐RNA–positive (viremic) patients but not in HCV‐RNA–negative patients in our sensitivity analyses. Several previous studies found similar associations, while other studies reported opposite findings . Potential reasons for the discrepant results in these studies are their smaller sample sizes, selection bias, lack of adjustment for possible confounders, and shorter follow‐up duration .…”
Section: Discussionmentioning
confidence: 67%
“…Several studies of large databases have recently addressed the association between HCV and kidney disease with conflicting results, and a recent meta‐analysis concluded that HCV was not significantly associated with the incidence of reduced estimated glomerular filtration rate (eGFR) but was positively associated with the presence of albuminuria and proteinuria in the general population . However, several of the previous studies had limitations such as modest sample size, low event rates, selection bias, and lack of proper end point definition (e.g., the use of a single eGFR <60 mL/min/1.73 m 2 to define incident CKD) .…”
mentioning
confidence: 99%
“…10 Recent studies suggest that HCV-infected patients with CKD have an accelerated rate of kidney function loss and an increased risk of progressing to ESRD. [14][15][16][17][18][19] In one study, Molnar et al 19 showed that HCVinfected patients with CKD had an increased mortality and an accelerated rate of progression to ESRD, raising the important question of whether treating to obtain a sustained virologic response defined as an undetectable viral load 12 weeks after completion of treatment (SVR12) would diminish the rate of decline in GFR.…”
Section: Hcv In Patients With Kidney Diseasementioning
confidence: 99%